BDX supply chain intelligence for Becton, Dickinson and Company: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Becton, Dickinson and Company (BDX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| WAT | Waters Corporation | 95% | Reciprocal relationship from WAT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from WAT graph: C is a standard technique and is utilized in a broad range of industries to det… |
| WATERS | WATERS | 92% | The Company granted Waters a worldwide, fully-paid, royalty-free, irrevocable, exclusive license to three patent families owned by the Company |
| EMBC | Embecta Corp. | 85% | Reciprocal relationship from EMBC graph: 2023 was $ million, $ million and $ million, respectively. Dollar amounts are in millions except per share amounts or as otherwise specified. 58 % of net reve… |
| ANGO | AngioDynamics, Inc. | 72% | Reciprocal relationship from ANGO graph: , accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities. The Company does not have assets or liabi… |
| AORT | Artivion, Inc. | 72% | Reciprocal relationship from AORT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these c… |
| CDNA | CareDx, Inc. | 72% | Reciprocal relationship from CDNA graph: Reciprocal relationship from BDX graph: Reciprocal relationship from CDNA graph: son and Company and Qiagen N.V. that are currently capable of supplying the i… |
| CTKB | Cytek Biosciences, Inc. | 72% | Reciprocal relationship from CTKB graph: Reciprocal relationship from BDX graph: Reciprocal relationship from CTKB graph: . See Note 18 to our consolidated financial statements included elsewhere in … |
| EW | Edwards Lifesciences Corporation | 72% | Reciprocal relationship from EW graph: eering or other unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or … |
| HBIO | Harvard Bioscience, Inc. | 72% | Reciprocal relationship from HBIO graph: nt, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Emka Technologies, Eppendorf AG, Hitachi, Instem plc, Kent Scientific Corp… |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 72% | Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both the blood oxygenation and blood monitoring. The components of the assembled product… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Reciprocal relationship from BDX graph: Reciprocal relationship from MMSI graph: Reciprocal relationship from BDX graph: Reciprocal relationship from MMSI gra… |
| NAUT | Nautilus Biotechnology, Inc. | 72% | Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT gra… |
| PYPD | PolyPid Ltd. | 72% | Reciprocal relationship from PYPD graph: we have incurred over the last two years pursuant to our research and development programs, please see “Item 5. Operating and Financial Review and Prospects— … |
| STE | STERIS plc | 72% | Reciprocal relationship from STE graph: to arrangements that provide rights (and, in certain cases, obligations) that could result in the Company acquiring the remaining equity interests in the inves… |
| TELA | TELA Bio, Inc. | 72% | Reciprocal relationship from TELA graph: cost as a percentage of Aroa’s cost of goods sold, and subject to a true-up adjustment, resulting in an amount equal to 27% of our net sales of our OviTex and… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 95% | USAspending awards from Department of Health and Human Services: $36,587,207 across 3 awards. 75A50121C00025 BECTON DICKENSON: MULTIPLEXED RESPIRATORY PANEL TESTS FOR THE BD VERITOR, THE BD MAX, AND … |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $8,579,230 across 7 awards. 36C25722P0002 BD REAGENTS AND SUPPLIES; 36C25720P0887 FLOW CYTOMETRY; 36C25725P0758 CTX MICROBIOLOGY AUTOMATION SYS… |
| ANGO | AngioDynamics, Inc. | 92% | Reciprocal relationship from ANGO graph: The Company made a one-time lump sum payment to BD in the amount of $ 7.0 million, $ 3.0 million which was paid within 5 business days of execution of the Set… |
| CDNA | CareDx, Inc. | 92% | Reciprocal relationship from CDNA graph: Reciprocal relationship from BDX graph: Reciprocal relationship from CDNA graph: Becton, Dickinson and Company, and Streck, which supplies us with cell prepar… |
| WAT | Waters Corporation | 92% | Reciprocal relationship from WAT graph: C is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composi… |
| SPINCO | SPINCO | 90% | The Company will provide certain services to SpinCo on a transitional basis to facilitate the transition of the Biosciences and Diagnostics Solutions Business to Waters |
| CTKB | Cytek Biosciences, Inc. | 72% | Reciprocal relationship from CTKB graph: . See Note 18 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information regarding ongoing legal proceedin… |
| EMBC | Embecta Corp. | 72% | Reciprocal relationship from EMBC graph: nt of property, plant, and equipment, stock-based compensation, and deferred income taxes 120.0 Change in in accounts payable and accrued expenses (68.9) Chan… |
| EW | Edwards Lifesciences Corporation | 72% | Reciprocal relationship from EW graph: eering or other unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or … |
| HBIO | Harvard Bioscience, Inc. | 72% | Reciprocal relationship from HBIO graph: nt activities to advance our position in the industry as a provider of life science equipment, software and services. We plan to pursue a balanced development… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), Sou… |
| NAUT | Nautilus Biotechnology, Inc. | 72% | Reciprocal relationship from NAUT graph: stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research programs, enabling their successes, and drivin… |
| STE | STERIS plc | 72% | Reciprocal relationship from STE graph: to arrangements that provide rights (and, in certain cases, obligations) that could result in the Company acquiring the remaining equity interests in the inves… |
| TELA | TELA Bio, Inc. | 72% | Reciprocal relationship from TELA graph: cost as a percentage of Aroa’s cost of goods sold, and subject to a true-up adjustment, resulting in an amount equal to 27% of our net sales of our OviTex and… |
| TELA | TELA Bio, Inc. | 72% | 04 per share) — — ( 298 ) — — — Issuance of shares under employee and other plans, net — ( 6 ) — 1 78 13 Share-based compensation — 59 — — — — Common stock held in trusts, net (a) — — — — 13 — Repurc… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| BDX-DEBT-BDX-BDX | 1.208% Notes due June 4, 2026 (BDX) | 94% | 1.208% Notes due June 4, 2026 BDX. Listed in 10-Q 2026-05-07. |
| BDX-DEBT-BDX-BDX31 | 3.519% Notes due February 8, 2031 (BDX31) | 94% | 3.519% Notes due February 8, 2031 BDX31. Listed in 10-Q 2026-05-07. |
| BDX-DEBT-BDX-BDX26 | 1.900% Notes due December 15, 2026 (BDX26) | 94% | 1.900% Notes due December 15, 2026 BDX26. Listed in 10-Q 2026-05-07. |
| BDX-DEBT-BDX-BDX32A | 3.828% Notes due June 7, 2032 (BDX32A) | 94% | 3.828% Notes due June 7, 2032 BDX32A. Listed in 10-Q 2026-05-07. |
| BDX-DEBT | Debt stack $16.8B | 90% | Market cache reports total debt of $16.8B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| BDX-OWNER-AUTO-OWNERS-INSURANCE-CO | Auto-Owners Insurance Co | 90% | 13F overlay lists Auto-Owners Insurance Co as top holder; 1469 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 100.00 | 2 | |
| QGEN | Qiagen N.V. | 100.00 | 2 | |
| MDXG | MiMedx Group, Inc. | 100.00 | 2 | |
| MDT | Medtronic plc | 100.00 | 2 | |
| SNN | Smith & Nephew plc | 100.00 | 2 | |
| PTIX | Protagenic Therapeutics, Inc. | 100.00 | 2 | |
| LAB | Standard BioTools Inc. | 100.00 | 2 | |
| GTLS | Chart Industries, Inc. | 100.00 | 2 | |
| NNDM | Nano Dimension Ltd. | 100.00 | 2 | |
| SNNUF | Smith & Nephew plc | 100.00 | 2 | |
| ALC | Alcon Inc. | 100.00 | 2 | |
| CTKB | Cytek Biosciences, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| AMGN | Amgen Inc. | 100.00 | 2 | |
| FSNUY | Fresenius SE & Co. KGaA | 100.00 | 2 | |
| CTSO | Cytosorbents Corporation | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 2 | |
| BIO | Bio-Rad Laboratories, Inc. | 100.00 | 2 | |
| STE | STERIS plc | 100.00 | 1 | ['customer', 'supplier'] |
| BSX | Boston Scientific Corporation | 100.00 | 2 | |
| MMSI | Merit Medical Systems, Inc. | 100.00 | 1 | ['customer', 'supplier'] |